bpc 157 injection site near injury vs systemic BPC-157 For Knee Pain: Early Reported Outcomes, A report on intra-articular BPC-157 for knee pain described high rates of improvement: ~92% with BPC-157 alone, ~75% when combined with thymosin beta-4, TB-500 Dosage Protocol: 3-Month Cycle

doi: 10.1297/cpe.23.107 100 ChiharaKShimatsuAHizukaNTanakaTSeinoYKatoforYet al

Switching up where you inject helps avoid soreness and ensures the shot works well

Discontinuing the injections may see a return to some of the deficiency symptoms listed above

Inadequate secretion of intrinsic factor, resulting from lesions that destroy the gastric mucosa (which can be caused by ingestion of corrosives, extensive tumors, and conditions associated with gastric atrophy, such as multiple sclerosis, certain endocrine disorders, iron deficiency, and subtotal gastrectomy) Structural lesions leading to vitamin B 12 deficiency, including regional ileitis, ileal reactions, and malignancies Competition for vitamin B 12 by intestinal parasites or bacteria